Julien Masliah-Planchon

11PUBLICATIONS
141CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Gene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 15, 2026
SHIVA02 Trial: Using Patients as Their Own Controls to Assess Efficacy of Therapies Based on Molecular Profiling in Patients with Refractory Cancer.

|Aug 10, 2026
DNMT3B Plays Antagonistic Roles with SMARCB1 and Is a Targetable Vulnerability in Rhabdoid Tumors.

|Mar 09, 2026
Prognostic factors in adult patients with medulloblastoma.

Ytel Garcilazo-Reyes, Pierre Dal Col, Franck Bielle

|Feb 24, 2025
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition.

Peter N Fiorica, Lisa Golmard, Jung Kim

|Dec 28, 2024
Nanopore sequencing as a cutting-edge technology for medulloblastoma classification.

Mathilde Filser, Jacob Torrejon, Kevin Merchadou

|Aug 29, 2024
Evaluation of Combined Chemotherapy and Genomic-Driven Targeted Therapy in Patient-Derived Xenografts Identifies New Therapeutic Approaches in Squamous Non-Small-Cell Lung Cancer Patients.

Didier Decaudin, Fariba Némati, Julien Masliah Planchon

Pageof 2

Frequent Collaborators

5 joint publications

Franck Bourdeaut

4 joint publications

Olivier Delattre

3 joint publications

Mathilde Filser

2 joint publications

Jerzy Klijanienko